Tassilo L A Wachsmann

6PUBLICATIONS
19CO-AUTHORS
Digital writingReaction engineering (excl. nuclear reactions)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 08, 2025
Durable epigenetic silencing with a TALE-based editor.

Tassilo L A Wachsmann, Lei S Qi

|Sep 26, 2024
Targeting epigenetic regulation and post-translational modification with 5-Aza-2' deoxycytidine and SUMO E1 inhibition augments T-cell receptor therapy.

Jessie S Kroonen, Anne K Wouters, Ilona J de Graaf

|Aug 11, 2023
Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma.

Tassilo L A Wachsmann, Miranda H Meeuwsen, Dennis F G Remst

|Mar 15, 2022
T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion.

Laura T Morton, Tassilo L A Wachsmann, Miranda H Meeuwsen

|Feb 07, 2022
Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure.

Tassilo L A Wachsmann, Anne K Wouters, Dennis F G Remst

|Nov 13, 2021
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML.

Dyantha I van der Lee, Georgia Koutsoumpli, Rogier M Reijmers

Pageof 1

Frequent Collaborators

5 joint publications

Mirjam H M Heemskerk

3 joint publications

Miranda H Meeuwsen

2 joint publications

J H Frederik Falkenburg

2 joint publications

Anne K Wouters